What Is the Medicare Likely to Benefit Notice? (2026)

Direct answer: what this notice means for you

Yes, the Medicare Likely to Benefit Notice is a genuine, CMS-mandated communication, not a scam letter. The notice tells you that, based on your 2026 drug costs, spreading payments through the Medicare Prescription Payment Plan (M3P) could ease your cash flow. Pharmacies trigger it once a single fill costs $600 or more out of pocket in 2026. Your Part D or Medicare Advantage drug plan mails a separate annual version. Joining stays optional, with no interest or fees.

What the Medicare Prescription Payment Plan Actually Is (2026)

Congress created the Medicare Prescription Payment Plan under the Inflation Reduction Act of 2022, and CMS rolled it out for the first time in 2025 alongside the new annual out-of-pocket cap for Part D drugs. Every enrollee in a standalone Part D plan or Medicare Advantage plan with drug coverage (MAPD) can opt in for 2026, regardless of income, drug list, or health status, and the program carries no application fee, no interest charge, and no credit check. A participant pays $0 out of pocket at the pharmacy counter and instead receives one consolidated bill each month from the plan sponsor covering that month's share of drug costs.

The 2026 Part D out-of-pocket cap sits at $2,100, up from $2,000 in 2025, and the payment plan applies only to costs that count toward that cap. Total spending for the year hitting the cap makes covered Part D drugs cost $0 for the rest of the 2026 plan year, whether or not a beneficiary joined the payment plan. The plan does not reduce total drug spending; it only changes the timing of payments, which is why CMS calls it a payment option rather than a discount or subsidy.

Who Sends the Likely to Benefit Notice and Why

Pharmacies and Part D plan sponsors both have a role in the 2026 Likely to Benefit Notice. A pharmacy must hand the beneficiary the standardized notice at the point of sale the moment a single prescription's out-of-pocket cost reaches $600, since CMS set that dollar figure as the point-of-sale notification threshold for 2026. That in-person notice is the beneficiary's fastest signal that a single fill just became expensive enough to make monthly spreading worthwhile.

Part D plan sponsors separately identify likely candidates using their own claims data collected through September of the plan year, then mail the CMS model Likely to Benefit Notice before the following plan year's Annual Enrollment Period. Sponsors must use the CMS-drafted notice text verbatim; the letter explains what the payment plan is, roughly what a participant's monthly bill could look like, and how to sign up. Neither version of the notice enrolls a beneficiary automatically.

How Medicare Advantage and Original Medicare Handle the Notice Differently

Medicare Advantage plans that bundle drug coverage (MA-PD plans) follow the identical 2026 notice rules as standalone Part D plans, since CMS applies the Medicare Prescription Payment Plan requirement to every Part D sponsor, not just stand-alone Prescription Drug Plans. A beneficiary in an MA-PD plan gets the pharmacy point-of-sale notice at the same $600 threshold and can receive the plan-mailed annual notice from the Medicare Advantage carrier instead of a separate Part D company.

Original Medicare beneficiaries who carry Medicare Part A (hospital coverage) and Medicare Part B (outpatient coverage) but never enrolled in a Part D drug plan, Medicare Advantage members whose plan carries no drug benefit, and Medigap policyholders never receive the Likely to Benefit Notice, because none of those coverage types generates the kind of prescription drug out-of-pocket cost the payment plan is designed to spread. The table above breaks down exactly which plan types participate.

What Participating Costs in 2026 (and What It Doesn't Save You)

Joining the Medicare Prescription Payment Plan costs nothing extra in 2026: no enrollment fee, no interest on the balance, and no penalty for opting out mid-year. What changes is only the timing. A beneficiary who owes $1,200 in drug costs for the rest of 2026 and opts in during January, with 12 billing months left, pays roughly $100 a month. The same $1,200 balance split starting in October, with only 3 billing months left, produces bills closer to $400 a month, which is why Medicare.gov stresses that opting in earlier in the year spreads costs further, as the example below shows.

How to Opt In to the Medicare Prescription Payment Plan

Enrollment in the Medicare Prescription Payment Plan runs year-round in 2026 rather than tying to the October 15 through December 7 Annual Enrollment Period. A beneficiary already enrolled in 2025 gets automatically renewed for 2026 under the newly finalized auto-renewal rule unless they actively opt out. A first-time participant contacts the Part D or Medicare Advantage plan sponsor directly, not Medicare.gov, since each plan processes its own opt-in requests and monthly billing. The numbered steps below cover the full 2026 process.

Alternatives, Grace Periods, and What Happens If You Fall Behind

Falling behind on a Medicare Prescription Payment Plan bill in 2026 does not cut off prescription drug coverage. Federal rules give every participant a two-month grace period to catch up on an overdue monthly bill, and paying the full overdue balance, or showing the plan good cause for the missed payment, restores standing in the payment plan. A participant who never catches up gets involuntarily terminated from the payment plan itself, though the underlying Part D or Medicare Advantage drug coverage continues without interruption.

Beneficiaries who decide the payment plan is not the right fit have other 2026 cost-relief options. Extra Help, the federal Low-Income Subsidy, eliminates most Part D cost-sharing for enrollees under roughly 150% of the Federal Poverty Level and works alongside or instead of the payment plan. Manufacturer patient assistance programs, State Pharmaceutical Assistance Programs (SPAPs) in states like Massachusetts and New Jersey, and simply paying at the pharmacy as usual up to the $2,100 2026 cap remain available regardless of whether a beneficiary opts into M3P. The Medicare Prescription Payment Plan itself only applies to Medicare Part D; it does not extend to ACA-compliant marketplace plans, which handle their own cost-sharing rules separately.

What is the Medicare Prescription Payment Plan (M3P)?

The Medicare Prescription Payment Plan lets anyone enrolled in a standalone Part D plan or a Medicare Advantage plan with drug coverage spread their 2026 out-of-pocket prescription costs into monthly bills from the plan instead of paying the full amount at the pharmacy. Congress created it under the 2022 Inflation Reduction Act. Participation is voluntary, carries no interest or fees, and does not lower the total amount owed, only when it gets paid.

Who sends the Medicare Likely to Benefit Notice, my pharmacy or my plan?

Both can. A pharmacy must hand you the standardized notice at the point of sale the moment a single prescription costs $600 or more out of pocket in 2026. Your Part D or Medicare Advantage drug plan separately mails an annual version to enrollees its claims data flags as likely to benefit, typically based on spending through September of the prior plan year.

What is the $600 threshold that triggers the pharmacy notice?

CMS set $600 as the 2026 point-of-sale threshold: once a single prescription fill's out-of-pocket cost hits that amount, the pharmacy must give you the Likely to Benefit Notice on the spot, even if you have never heard of the Medicare Prescription Payment Plan before. It is a one-time trigger tied to that specific transaction, not a running annual total.

Do I have to enroll in the Medicare Prescription Payment Plan if I get this notice?

No. Receiving the Likely to Benefit Notice does not enroll you automatically and creates no obligation. You choose whether to opt in by contacting your Part D or Medicare Advantage plan directly by phone, mail, or online. If you already opted in during 2025, you are automatically renewed for 2026 unless you actively opt out.

Does the Medicare Prescription Payment Plan save me money?

No, not directly. The program only changes when you pay for covered Part D drugs, spreading the 2026 total into monthly installments instead of one lump sum at the pharmacy. Your total out-of-pocket spending for the year is unaffected and still caps at $2,100 in 2026 either way. The value is cash-flow relief, not a discount.

What is the 2026 out-of-pocket cap for Part D drugs?

The 2026 Medicare Part D out-of-pocket cap is $2,100 for covered drugs, up from $2,000 in 2025, under the Inflation Reduction Act's phased-in cost cap. Once total spending toward that cap is reached, covered Part D drugs cost $0 for the remainder of the 2026 plan year, regardless of whether a beneficiary used the Medicare Prescription Payment Plan.

Can Medicare Advantage enrollees get the Likely to Benefit Notice?

Yes, if the Medicare Advantage plan includes drug coverage (an MA-PD plan). CMS requires MA-PD sponsors to follow the same 2026 notice rules as standalone Part D plans, including the $600 pharmacy trigger and the annual claims-based mailing. Medicare Advantage enrollees whose plan carries no drug benefit at all never receive the notice, since there is no drug spending to spread.

How do I opt in or opt out of the Medicare Prescription Payment Plan?

Contact your Part D or Medicare Advantage plan sponsor directly, not Medicare.gov, since each plan processes its own enrollment and monthly billing for 2026. You can opt in any time during the year online, by phone, or by mail, and opt out just as easily; opting out does not affect your underlying Part D or Medicare Advantage drug coverage.